Furthermore, the lack of association between the CSPG4 expression in the EVs and patient outcome could be due to the fact that we analysed the total EVs in the serum, and not only tumour cell derived EVs and hence, the tumour associated changes could be masked, calling for enrichment of tumour derived EVs in further studies. This evidence concerns the gene CSPG4 and neoplasm.